Loading
Life sciences · Journal article
Biodata Mining · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Lung cancer remains a leading cause of cancer-related mortality worldwide, and manual delineation of tumors on computed tomography (CT) is time-consuming and prone to inter-observer variability. This study systematically evaluates nine deep learning configurations for automated lung tumor segmentation across the full spectrum of tumor sizes, providing evidence-based guidance for architectural selection in clinical applications. Three encoder-decoder architectures (U-Net, U-Net++, UNet 3+) were combined with three pre-trained backbones (VGG16, ResNet50, Xception), yielding nine configurations. A combined dataset of 161 subjects (63 public Kaggle cases, 1,647 slices; 98 patients from Imam Reza Hospital, Tabriz, 500 slices, collected retrospectively in 2025) was preprocessed, yielding 1,322 tumor-containing CT slices standardized to 128 × 128 pixels. A morphological pipeline (CLAHE, Otsu thresholding, automated lung extraction) isolated pulmonary structures. Models were trained with combined Dice-Focal loss and Adam optimizer via 5-fold stratified cross-validation (80/20 split). Tumors were also retrospectively stratified into five size categories (diameter approximately 0.6–30.2 mm) and evaluated using both generalist and independently trained size-specific models. Seven metrics (IoU, Dice, sensitivity, specificity, precision, accuracy, F1-score) were computed, with significance evaluated via ANOVA and Kruskal-Wallis tests. U-Net with VGG16 achieved the highest overall performance (IoU: 0.8838 ± 0.0229, Dice: 0.9342 ± 0.0164), while U-Net + + with Xception and UNet 3 + with VGG16 showed superior stability (Dice SD: 0.0009). UNet 3 + with ResNet50 attained the highest sensitivity (0.9338 ± 0.0142) and precision (0.9449 ± 0.0059). All configurations achieved specificity ≥ 0.9991 and accuracy ≥ 0.9980 (ANOVA p < 0.001; Kruskal-Wallis p < 0.001 for IoU/Accuracy, p < 0.01 for Dice). Performance improved with tumor size, from IoU 0.7912 ± 0.0287 (smallest category) to 0.9106 ± 0.0131 (largest), with size-specific training yielding only marginal gains (0.3–1.3% points) over the generalist model. The systematic architectural comparison, including size-stratified evaluation, provides evidence-based guidance for model selection in lung tumor segmentation, with morphological preprocessing effectively reducing false positives, supporting applications in radiation therapy planning and computer-aided detection.